1st Quarter - Report

TARPLIN, DOWNS & YOUNG, LLC for ELI LILLY AND COMPANY

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

no specific bills, Medicare Part D, Value based purchasing, Medicare Part B

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
CHARLOTTE SPEARS IVANCIC —
ELIZABETH T MURRAY —
PAMELA SMITH —
JENNIFER B YOUNG —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

S.Con.Res. 3 - Senate budget resolution

LobbyistCovered position, as disclosed
RAISSA H DOWNS Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Staff Dir., Sub. Cmte. on Employment, Sen. HELP Cmte.
MICHELLE P EASTON Chief Health Counsel, Sen. Cmte. on Finance; Staff Dir., Senate Aging Cmte.; Leg. Asst., Congressman Billy Tauzin
CHARLOTTE SPEARS IVANCIC Leg. Counsel, Senator Jim DeMint; Health Counsel, Majority Leader Bill Frist; Counsel and Budget Analyst, House Budget Cmte.; Asst. to the Speaker for Policy, Speaker John Boehner
ELIZABETH T MURRAY Senior Policy Advisor, Democratic Whip Steny Hoyer; Legislative Asst. for Rep. Mike Thompson, Rep. Bob Matsui, and Senator Bob Graham
PAMELA SMITH Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Senate HELP Cmte; Staff Dir., Senate HELP Cmte; Counselor to the Asst. AG, Civil Div., Dept of Justice; Spec Counsel, Ofc of Leg. Affairs, Dept of Justice; Counsel and LA, Senator Carol Moseley-Braun
JENNIFER B YOUNG Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on Finance

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S.Con.Res. 3 (115th)

Health Issues HCR

H.R. 1628 - American Health Care Act of 2017 PL 114-255 - 21st Century Cures, implementation no specific bills; user fee reauthorization, non-interference S. 771 - Improving Access to Affordable Prescription Drugs Act S. 637 - Creating Transparency to Have Drug Rebates Unlocked Act of 2017 Stopping the Pharmaceutical Industry From Keeping Drugs Expensive Act of 2017 S. 469 - Affordable and Safe Prescription Drug Importation act H.R. 749 - Lower Drug Costs Through Competition Act

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
CHARLOTTE SPEARS IVANCIC —
ELIZABETH T MURRAY —
PAMELA SMITH —
JENNIFER B YOUNG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 771 (115th), H.R. 749 (115th), S. 469 (115th), S. 637 (115th), H.R. 1628 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.